Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

MorphoSys

Tracked across 2 events · 12 articles · First seen Jul 23, 2026 · Last active Sep 10, 2026

Sentiment
-10
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 -20
Business
Artisan Partners Asset Management, a top-20 shareholder in Swiss drugmaker Novartis, publicly called for a shake-up of the company's board to improve corporate governance and oversight of acquisitions. David Samra, managing director at Artisan Partners…
Impact: German biotech acquired by Novartis in 2024 and later written down, cited by Samra as evidence of a poor acquisition track record.
Sep 10, 2026 · 6 articles
1 0
Business
Impact: MorphoSys, now part of Novartis, was Erkel's previous employer where he led immuno-oncology programs.
Jul 23, 2026 · 6 articles
ERGEN INTELLIGENCE
Track MorphoSys live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.